Purchase Order 75N92025P00186
Award Date
4/29/25
Potential Completion Date
10/29/25
Potential Value
$15K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Psomagen Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The $23,030 contract is for OLINK HT ANALYSIS services, which likely refers to genomic sequencing and analysis capabilities provided by Psomagen. The contract has an ultimate completion date of July 29, 2025 and was awarded on July 30, 2024...
This federal contract award to Psomagen Inc., a for-profit manufacturer, provides a Firm Fixed Price purchase order valued at $113,247.00 for the OLINK EXPLORE HT PROCESSING SERVICE. The contract is issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, and will support the institute's research on neurological disorders such as ALS, long COVID, and HIV. The contract requires Psomagen to perform the OLINK Explore HT Biomarker discovery protocol...
The National Heart, Lung and Blood Institute (NHLBI) has awarded a $14,097.60 firm fixed price purchase order to Psomagen Inc., a for-profit organization and manufacturer of goods, to provide transcriptome profiling of human bone marrow core samples. The work supports the Hematology Branch at NHLBI. This is not a set-aside contract. Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities. The company has a $500 million single-award Indefinite...
This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...
This $17,154.00 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Psomagen Inc. for library preparation and sequencing services. Psomagen is a for-profit organization that manufactures goods and provides multiomics contract laboratory services, including whole genome, RNA, and epigenomic sequencing. The company has previously supported research at...
This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract, valued at $4,942.00, is for DNA sequencing services. It is not a set-aside contract. The contract supports NIAID's research efforts, potentially including work on neurodegenerative diseases, cancer, and infectious diseases. Psomagen has previously received...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
This federal contract award, valued at $44,940.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit manufacturer of genomic sequencing and bioinformatics services. The contract is for "SEQUENCING NOVASEQX 25B 150PE, FLOW CELL" and has a firm fixed-price structure with a completion date of November 16, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and has...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Child Health and Human Development to Psomagen Inc., a for-profit manufacturer, for genomic sequencing services. The potential value of the contract is $187,080.00 and the period of performance runs from September 26, 2018 to September 25, 2019. The contract does not have a set-aside designation. Psomagen is a multiomics contract laboratory service and data analysis...
This federal contract award was made by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, valued at $25,000.00, is a firm-fixed price Purchase Order for Psomagan to provide whole genome sequencing services in order to conduct genetic screening of VEXAS patients. The contract has no set-aside designation and is scheduled for completion by September...